D-002-2013 Class III Terminated

Recalled by McKesson Packaging Services — Concord, NC

FDA drug recall D-002-2013 was initiated by McKesson Packaging Services on Mar 29, 2012 and is designated Class III. Reason for recall: Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point. The recall status is terminated (terminated Apr 11, 2013). Affected quantity: 674 cartons.

Recall details

Product Type
Drugs
Report Date
Oct 10, 2012
Initiation Date
Mar 29, 2012
Termination Date
Apr 11, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
674 cartons

Product description

buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10) per carton, Rx only, Mfg By: CMIC-VPS Corporation, Cranbury, New Jersey 08512; blister barcode N (01)003 63739 450 10 3, Dist By: McKesson Packaging, Concord, NC 28027; NDC 63739-450-10, carton barcode 6373945010.

Reason for recall

Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point.

Distribution pattern

Nationwide

Code information

Lot #: 0075375, 0074584, Exp 08/12

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-002-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-002-2013. Report a data issue: hello@regdatalab.com.